hVIVO
London · Founded 1988
About hVIVO
hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker ‘HVO’).
Company Facts
- Founded: 1988
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $2.6M
- Funding stage: IPO
- Last round: Series B (Oct 2009)
- Ticker: lse:HVO
- Website: hvivo.com
- Phone: +44 20 7756 1300
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hvivo-2905333 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.